Jump to content

Page values for "Insulin Detemir"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringInsulin detemir
brandStringLevemir, Levemir FlexTouch (US discontinuation announced 2024)
structureFile
classesList of String, delimiter: ,[[:Category:Insulins|Insulin]] [[:Category:Long-acting_insulins|Long-acting insulin analog]] [[:Category:Basal_insulins|Basal insulin]]
mechanismString
usesString'"`UNIQ--vote-00001372-QINU`"', '"`UNIQ--vote-00001373-QINU`"'
starting_doseString~10 units SC at the same time daily, or 0.1-0.2 units/kg/d; titrate by fasting glucose. Frequently dosed BID at moderate-to-high doses
preparationsString100 U/mL FlexTouch pen, vial
fda_maxStringTitrated to glucose
pill_idText
routesList of String, delimiter: ,Subcutaneous
onsetString1-2 hours
durationString~12-24 hours (dose-dependent; BID dosing often needed at higher doses)
halflifeString~7 hours apparent'"`UNIQ--ref-00001374-QINU`"'
bioavailabilityString~60% from subcutaneous depot (reduced by reversible albumin binding via the myristic acid side chain that also extends duration)'"`UNIQ--ref-00001375-QINU`"'
pregnancyStringOne of the better-studied basal insulin analogs in pregnancy; reassuring data.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US